Alnylam Pharmaceuticals
ALNY
#549
Rank
A$59.86 B
Marketcap
$462.40
Share price
2.60%
Change (1 day)
98.13%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: $478.07 AUD on 2024-10-16

Lowest end of day price: $6.28 AUD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$24.66 4.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$1,051 0.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$121.42 3.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.88 0.56%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.29 5.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$176.71-0.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$88.97-1.70%๐Ÿ‡ซ๐Ÿ‡ท France
$25.74 0.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel